Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May:163:108151.
doi: 10.1016/j.diabres.2020.108151. Epub 2020 Apr 17.

COVID-19 and diabetes management: What should be considered?

Antonio Ceriello  1 , Anca Pantea Stoian  2 , Manfredi Rizzo  3
Affiliations

COVID-19 and diabetes management: What should be considered?

Antonio Ceriello et al. Diabetes Res Clin Pract. 2020 May.
No abstract available

Keywords: COVID-19; Cardiovascular disease; DPP4; Diabetes; GLP-1RA; Hydroxychloroquine; Pioglitazone; SGLT-2.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest AC has given lectures, received honoraria and research support, and participated in conferences, advisory boards and clinical trials sponsored by Abbott, Astra Zeneca, BD, Berlin Chemie, Boehringer Ingelheim, Eli Lilly, Janssen, Mitsubishi, Mundipharma, Novo Nordisk, Roche Diagnostics. APS has given lectures, received honoraria and research support, and participated in conferences, advisory boards and clinical trials sponsored by Astra Zeneca, Coca-Cola, Eli Lilly, Janssen, Merck, Medtronic, Novo Nordisk, Roche Diabetes, Sanofi. APS is currently Vice-President, National Diabetes Commission, Ministry of Health, Romania. MR has given lectures, received honoraria and research support, and participated in conferences, advisory boards and clinical trials sponsored by AstraZeneca, Boehringer Ingelheim, Kowa, Eli Lilly, Merck Sharp & Dohme, Novo Nordisk, Novartis, Roche Diagnostics, Sanofi and Servier. MR is currently Director, Clinical Medical & Regulatory Department, Novo Nordisk Europe East and South.

References

    1. Ceriello A. Management of diabetes today: An exciting confusion. Diabetes Res Clin Pract. 2020;162:108129. doi: 10.1016/j.diabres.2020.108129. - DOI - PubMed
    1. Bhadada S.K. Should anti-diabetic medications be reconsidered amid COVID-19 pandemic? Diabetes Res Clin Pract. 2020;163 doi: 10.1016/j.diabres.2020.108146. - DOI - PMC - PubMed
    1. Fadini G.P., Morieri M.L., Longato E., Avogaro A. Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Investig. 2020 doi: 10.1007/s40618-020-01236-2. - DOI - PMC - PubMed
    1. Yang J., Zheng Y., Gou X., Pu K., Chen Z., Guo Q. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis. 2020 doi: 10.1016/j.ijid.2020.03.017. - DOI - PMC - PubMed
    1. Grasselli G., Zangrillo A., Zanella A., Antonelli M., Cabrini L., Castelli A., Cereda D., Coluccello A., Foti G., Fumagalli R., Iotti G., Latronico N., Lorini L., Merler S., Natalini G., Piatti A., Ranieri M.V., Scandroglio A.M., Storti E., Cecconi M., Pesenti A., COVID-19 Lombardy ICU Network Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020:e205394. doi: 10.1001/jama.2020.5394. - DOI - PMC - PubMed